| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Addressing the inequity of acute respiratory distress syndrome
|
Summers, Charlotte
|
|
|
11 |
2 |
p. 119-121
|
artikel
|
| 2 |
A new paradigm is needed to explain long COVID
|
Saunders, Chloe
|
|
|
11 |
2 |
p. e12-e13
|
artikel
|
| 3 |
Beyond the veil
|
Liddicoat, Patrick
|
|
|
11 |
2 |
p. 137-138
|
artikel
|
| 4 |
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES): an international, multicentre, retrospective cohort study
|
Schmidt, Matthieu
|
|
|
11 |
2 |
p. 163-175
|
artikel
|
| 5 |
Correction Lancet Respir Med 2022; 10: 937–48
|
|
|
|
11 |
2 |
p. e15
|
artikel
|
| 6 |
Cystic fibrosis: a call for papers for ECFS 2023
|
Grainger, Emma
|
|
|
11 |
2 |
p. 128
|
artikel
|
| 7 |
Differing effects of mepolizumab across the life course
|
Bush, Andrew
|
|
|
11 |
2 |
p. 123-125
|
artikel
|
| 8 |
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
|
Tartof, Sara Y
|
|
|
11 |
2 |
p. 176-187
|
artikel
|
| 9 |
Fighting sepsis: still a long way to go
|
Machado, Flavia R
|
|
|
11 |
2 |
p. 129-131
|
artikel
|
| 10 |
Flavia Machado—a Latin American leader in sepsis
|
Kirby, Tony
|
|
|
11 |
2 |
p. 134
|
artikel
|
| 11 |
Heart: anatomy and function
|
Dosani, Sabina
|
|
|
11 |
2 |
p. 135-136
|
artikel
|
| 12 |
In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study
|
Lorusso, Roberto
|
|
|
11 |
2 |
p. 151-162
|
artikel
|
| 13 |
Integrating morphology and treatable traits into the management of ILD
|
Marinescu, Daniel-Costin
|
|
|
11 |
2 |
p. 117-119
|
artikel
|
| 14 |
Moving away from zero COVID in China
|
Burki, Talha
|
|
|
11 |
2 |
p. 132
|
artikel
|
| 15 |
Rise in group A streptococcal infections in England
|
Venkatesan, Priya
|
|
|
11 |
2 |
p. e16
|
artikel
|
| 16 |
Safety and reactogenicity of second booster doses for mRNA vaccines
|
Wilder-Smith, Annelies
|
|
|
11 |
2 |
p. 112-113
|
artikel
|
| 17 |
Safety of the fourth COVID-19 BNT162b2 mRNA (second booster) vaccine: a prospective and retrospective cohort study
|
Yechezkel, Matan
|
|
|
11 |
2 |
p. 139-150
|
artikel
|
| 18 |
Silent Pandemic
|
Burki, Talha
|
|
|
11 |
2 |
p. 133
|
artikel
|
| 19 |
Strengthening clinical research in children and adolescents
|
The Lancet Respiratory Medicine,
|
|
|
11 |
2 |
p. 111
|
artikel
|
| 20 |
Thank you to The Lancet Respiratory Medicine's clinical and statistical peer reviewers in 2022
|
The Lancet Respiratory Medicine Editors,
|
|
|
11 |
2 |
p. e17-e19
|
artikel
|
| 21 |
The elusive goal of COVID-19 vaccine immunity
|
Abu-Raddad, Laith J
|
|
|
11 |
2 |
p. 115-117
|
artikel
|
| 22 |
The future of paediatric acute respiratory distress syndrome
|
Carlton, Erin F
|
|
|
11 |
2 |
p. 121-123
|
artikel
|
| 23 |
Treatable traits in interstitial lung diseases: a call to action
|
Amati, Francesco
|
|
|
11 |
2 |
p. 125-128
|
artikel
|
| 24 |
Underappreciated causes of obstructive lung disease
|
Samhouri, Bilal F
|
|
|
11 |
2 |
p. e14
|
artikel
|
| 25 |
Understanding clinical and biological heterogeneity to advance precision medicine in paediatric acute respiratory distress syndrome
|
Kneyber, Martin C J
|
|
|
11 |
2 |
p. 197-212
|
artikel
|
| 26 |
Usual interstitial pneumonia as a stand-alone diagnostic entity: the case for a paradigm shift?
|
Selman, Moisés
|
|
|
11 |
2 |
p. 188-196
|
artikel
|
| 27 |
VV-ECMO in severe COVID-19: multidimensional perspectives on the use of a complex treatment
|
Teijeiro-Paradis, Ricardo
|
|
|
11 |
2 |
p. 113-115
|
artikel
|
Tijdschrift beschrijving